Mathew Blackman
Stock Analyst at Stifel
(3.92)
# 522
Out of 4,843 analysts
59
Total ratings
51.16%
Success rate
11.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $6.47 | +8.19% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $19.82 | +56.41% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $266.97 | +19.11% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $11.86 | +110.79% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $17.24 | +45.01% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $325.03 | -9.85% | 3 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $59.18 | +58.84% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $11.26 | +113.14% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.27 | +136.22% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $85.80 | +16.55% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $12.43 | +28.72% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $8.95 | +22.91% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $6.47
Upside: +8.19%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $19.82
Upside: +56.41%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $266.97
Upside: +19.11%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $11.86
Upside: +110.79%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $17.24
Upside: +45.01%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $325.03
Upside: -9.85%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $59.18
Upside: +58.84%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $11.26
Upside: +113.14%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.27
Upside: +136.22%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $85.80
Upside: +16.55%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $12.43
Upside: +28.72%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $8.95
Upside: +22.91%